The purpose of this extension study is to find out more about the safety and efficacy of APD334 for the treatment of moderately to severely active ulcerative colitis. APD334 is an experimental drug which has not yet been approved by Health Authorities in any country of the world for the treatment of moderately or severely…
Ulcerative Colitis (APD334-005)